Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACH (Research to Assess SVS Safety and Effectiveness for the Treatment of Severe EmphysemA in China) SVS Control Patient Cross-Over Study

NCT02914340 is registered in ClinicalTrials.gov with Olympus Corporation of the Americas as lead sponsor.

NCT NCT02914340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACH (Research to Assess SVS Safety and Effectiveness for the Treatment of Severe EmphysemA in China) SVS Control Patient Cross-Over Study
Lead sponsor
Olympus Corporation of the Americas
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
September 30, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema